Meet Dr. Kathryn Whitehead, UBC's new Eddie Goldenberg Research Chair of Canada in Translational Drug Delivery.
Dr. Whitehead is a leading figure in lipid nanoparticle drug delivery, a field that has rapidly grown since its use in the delivery of COVID-19 vaccines. Her work has fundamentally advanced the transport of fragile therapeutic molecules into the specific cells and organs where they are needed. She will be joining the @ubcappscience and School of Biomedical Engineering (Faculty of Medicine and Faculty of Applied Science) at UBC Vancouver in summer 2027.
"I'm an engineer because I like to make things that work, and I've focused on biomedicine because I want to improve the lives of patients and the people who love them."
Learn more about Dr. Whitehead and the research she's bringing to UBC: bit.ly/4sNa1T9
Dr. Whitehead is a leading figure in lipid nanoparticle drug delivery, a field that has rapidly grown since its use in the delivery of COVID-19 vaccines. Her work has fundamentally advanced the transport of fragile therapeutic molecules into the specific cells and organs where they are needed. She will be joining the @ubcappscience and School of Biomedical Engineering (Faculty of Medicine and Faculty of Applied Science) at UBC Vancouver in summer 2027.
"I'm an engineer because I like to make things that work, and I've focused on biomedicine because I want to improve the lives of patients and the people who love them."
Learn more about Dr. Whitehead and the research she's bringing to UBC: bit.ly/4sNa1T9